To assess whether the anti-tumor activity of 5a-HSA was related to the activation of an immune response, we investigated the effect of 5a-HSA alone and in combination with an anti-CD8 depleting antibody in the WEHI-164 fibrosarcoma model. The gene discussed is CD8A; the disease is neoplasm.